Bradley’s legacy lives on

In life, it’s often said to get things done it’s not a case of what you know but who you know.

In the case of Gemma Lowery, she has made it her business to not only know her facts, but to know the right people.

On the evidence of the fantastic news regarding a life-saving treatment for young cancer victims, her proactive work with the Bradley Lowery Foundation has paid dividends.

Earlier this year we reported how Gemma took her fight for life saving drug treatment to Health Secretary Jeremy Hunt.

She argued that the drug dinutuximab beta should be freely available to children with the same cancer that took the life of her boy Bradley.

It had already been recommended for rejection by NICE who claimed it was too expensive and not costeffective.

As we reveal today, the treatment is set to be made available on the NHS.

Dr Juliet Gray, of the University of Southampton has revealed just how vital this drug will be to youngsters.

She said: “By harnessing the body’s own immune system, dinutuximab beta has shown it can target and attack this cancer very effectively in some patients. For some children this could mean extra weeks or months with their families, for others it may even lead to them becoming cancerfree for a long period of time.”

What a fantastic victory for all those who have campaigned for this drug.

Gemma and the Bradley Lowery Foundation have undoubtedly played a part in getting this drug into the NHS and, as such, giving new life to desperately ill children.

A better legacy to Bradley’s life, she could not have hoped for. Brilliant news.